PDE5 inhibitor and nitrate — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Severe hypotension from combined vasodilator effect
Nitrates and phosphodiesterase-5 inhibitors can cause a marked fall in blood pressure when used together. The sale should not proceed and the patient should be referred to their prescriber. In this scenario, the correct option is severe hypotension from combined vasodilator effect. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.
Reference: BNF; MEP